Chronic Lymphocytic Leukemia Cells in a Lymph Node Microenvironment Depict Molecular Signature Associated with an Aggressive Disease-Reference-Cited by-同舟云学术

Chronic Lymphocytic Leukemia Cells in a Lymph Node Microenvironment Depict Molecular Signature Associated with an Aggressive Disease

Published:2014-01 Issue:1 Volume:20 Page:290-301
ISSN:1076-1551
Container-title:Molecular Medicine
language:en
Short-container-title:Mol Med

Author:

Mittal Amit K.,Chaturvedi Nagendra K.,Rai Karan J.,Gilling-Cutucache Christine E.,Nordgren Tara M.,Moragues Margaret,Lu Runqing,Opavsky Rene,Bociek Greg R.,Weisenburger Dennis D.,Iqbal Javeed,Joshi Shantaram S.

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.2119/molmed.2012.00303.pdf

Reference45 articles.

1. Chiorazzi N. (2007) Cell proliferation and death: forgotten features of chronic lymphocytic leukemia B cells. Best Pract. Res. Clin. Haematol. 20:399–413.

2. Messmer BT, et al. (2005) In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J. Clin. Invest. 115:755–64.

3. Defoiche J, et al. (2008) Reduction of B cell turnover in chronic lymphocytic leukaemia. Br. J. Haematol. 143:240–7.

4. Chiorazzi N, Rai KR, Ferrarini M. (2005) Chronic lymphocytic leukemia. N. Engl. J. Med. 352:804–15.

5. Burger JA, Kipps TJ. (2002) Chemokine receptors and stromal cells in the homing and homeostasis of chronic lymphocytic leukemia B cells. Leuk. Lymphoma. 43:461–6.

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stromal cells engineered to express T cell factors induce robust CLL cell proliferation in vitro and in PDX co-transplantations allowing the identification of RAF inhibitors as anti-proliferative drugs;Leukemia;2024-06-14

2. Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical Effects;Cancer Research Communications;2024-05-22

3. Novel spirocyclic dimer, SpiD3, targets chronic lymphocytic leukemia survival pathways with potent preclinical effects;2024-02-03

4. Role of the tumor microenvironment in CLL pathogenesis;Seminars in Hematology;2023-12

5. Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL;Blood Advances;2023-11-17